Novartis AG Adjustments For Increase Decrease In Trade Account Payable
Novartis AG (NVS) reported Adjustments For Increase Decrease In Trade Account Payable of -$273.00 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-04.
Financial Statements › Notes
ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable · last filed 2026-02-04
- Novartis AG adjustments for increase decrease in trade account payable for the quarter ending 2025-06-30 was -$143.00M.
- Novartis AG adjustments for increase decrease in trade account payable for the quarter ending 2024-06-30 was -$142.00M, a 294.52% decline year-over-year.
- Novartis AG adjustments for increase decrease in trade account payable for the quarter ending 2023-06-30 was $73.00M, a 563.64% increase year-over-year.
- Novartis AG adjustments for increase decrease in trade account payable for the quarter ending 2022-06-30 was $11.00M.
| Period end | Adjustments For Increase Decrease In Trade Account Payable 3 month | Adjustments For Increase Decrease In Trade Account Payable 3 month as first filed | Adjustments For Increase Decrease In Trade Account Payable 6 month | Adjustments For Increase Decrease In Trade Account Payable 6 month as first filed | Adjustments For Increase Decrease In Trade Account Payable 12 month | Adjustments For Increase Decrease In Trade Account Payable 12 month as first filed |
|---|---|---|---|---|---|---|
| 2025-12-31 | -$273.00M 20-F · filed 2026-02-04 | |||||
| 2025-06-30 | -$143.00M 6-K · filed 2025-07-17 | -$315.00M 6-K · filed 2025-07-17 | ||||
| 2024-12-31 | -$105.00M 20-F · filed 2026-02-04 | |||||
| 2024-06-30 | -$142.00M 6-K · filed 2025-07-17 | -$551.00M 6-K · filed 2025-07-17 | ||||
| 2023-12-31 | $479.00M 20-F · filed 2026-02-04 | |||||
| 2023-06-30 | $73.00M 6-K · filed 2024-07-18 | $127.00M 6-K · filed 2023-07-18 | $99.00M 6-K · filed 2024-07-18 | $214.00M 6-K · filed 2023-07-18 | ||
| 2022-12-31 | -$181.00M 20-F · filed 2025-01-31 | -$48.00M 20-F · filed 2023-02-01 | ||||
| 2022-06-30 | $11.00M 6-K · filed 2023-07-18 | -$132.00M 6-K · filed 2023-07-18 | ||||
| 2021-12-31 | -$111.00M 20-F · filed 2024-01-31 | -$21.00M 20-F · filed 2022-02-02 | ||||
| 2020-12-31 | -$324.00M 20-F/A · filed 2023-05-15 | |||||
| 2019-12-31 | $553.00M 20-F · filed 2022-02-02 | |||||
| 2018-12-31 | $252.00M 20-F · filed 2021-01-26 | $309.00M 20-F · filed 2019-01-30 | ||||
| 2017-12-31 | $82.00M 20-F · filed 2020-01-29 | $58.00M 6-K · filed 2018-01-24 | ||||
| 2016-12-31 | -$587.00M 20-F · filed 2019-01-30 | |||||
| 2015-12-31 | $378.00M 6-K · filed 2018-01-24 |